2025 China Drug Catalog Boosts Access with 114 ...

By HEOR Staff Writer

December 9, 2025

Expansion of Coverage in the 2025 National Basic Medical Insurance Drug Catalog In this update we highlight updates and implications of the 2025 Nationa...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Navigating Novo Nordisk Board Changes: Leadership for Growth and Strategy
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
Addressing GLP-1 Access Inequity: Lessons from HIV/AIDS Mobilization
Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascul...
Insights on GLP-1 Therapy in Bariatric Surgery Patients
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies
T1 Diabetes Care with an Implantable Glucose Device
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share